Conference Reports for NATAP

66th Annual Meeting of the American Association for the Study of Liver Diseases Boston, MA Nov 13-17 2015 Back

Daclatasvir Exposure Alone Does Not Explain HCV Relapse in HIV-HCV Coinfected Patients Receiving Daclatasvir Plus Sofosbuvir with Ritonavir-Boosted Darunavir in the ALLY-2 Study       Reported by Jules Levin AASLD 2015 Nov 13-17 San Francisco, CA   Garimella T, Gandhi Y, Wang R, Ackerman P, Liu Z, Raybon J, Cirincione B, LaCreta F, Eley T Bristol-Myers Squibb Research and Development, Princeton, NJ